nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimexolone—NR3C1—Fluoxymesterone—breast cancer	0.262	1	CbGbCtD
Rimexolone—Testolactone—Exemestane—breast cancer	0.0466	0.0745	CrCrCtD
Rimexolone—Prednisone—Exemestane—breast cancer	0.0417	0.0667	CrCrCtD
Rimexolone—Fluprednidene Acetate—Exemestane—breast cancer	0.0387	0.062	CrCrCtD
Rimexolone—Loteprednol—Exemestane—breast cancer	0.0387	0.062	CrCrCtD
Rimexolone—Methylprednisolone—Exemestane—breast cancer	0.0362	0.0579	CrCrCtD
Rimexolone—Prednisolone—Exemestane—breast cancer	0.0354	0.0567	CrCrCtD
Rimexolone—Hydrocortamate—Fluoxymesterone—breast cancer	0.0343	0.0549	CrCrCtD
Rimexolone—Testolactone—Fluoxymesterone—breast cancer	0.0323	0.0517	CrCrCtD
Rimexolone—Amcinonide—Fluoxymesterone—breast cancer	0.0297	0.0475	CrCrCtD
Rimexolone—Clobetasol propionate—Fluoxymesterone—breast cancer	0.0289	0.0463	CrCrCtD
Rimexolone—Desoximetasone—Fluoxymesterone—breast cancer	0.0275	0.044	CrCrCtD
Rimexolone—Mometasone—Fluoxymesterone—breast cancer	0.0268	0.043	CrCrCtD
Rimexolone—Loteprednol—Fluoxymesterone—breast cancer	0.0268	0.043	CrCrCtD
Rimexolone—Fluprednidene Acetate—Fluoxymesterone—breast cancer	0.0268	0.043	CrCrCtD
Rimexolone—Triamcinolone—Fluoxymesterone—breast cancer	0.0268	0.043	CrCrCtD
Rimexolone—Fluorometholone—Fluoxymesterone—breast cancer	0.0268	0.043	CrCrCtD
Rimexolone—Dexamethasone—Fluoxymesterone—breast cancer	0.0262	0.042	CrCrCtD
Rimexolone—Betamethasone—Fluoxymesterone—breast cancer	0.0262	0.042	CrCrCtD
Rimexolone—Prednisolone—Fluoxymesterone—breast cancer	0.0246	0.0393	CrCrCtD
Rimexolone—Hydrocortisone—Fluoxymesterone—breast cancer	0.0236	0.0377	CrCrCtD
Rimexolone—Nerve injury—Paclitaxel—breast cancer	0.00201	0.0356	CcSEcCtD
Rimexolone—Scab—Fluorouracil—breast cancer	0.00162	0.0287	CcSEcCtD
Rimexolone—Dry eye—Toremifene—breast cancer	0.00131	0.0233	CcSEcCtD
Rimexolone—Lacrimation increased—Ixabepilone—breast cancer	0.00128	0.0228	CcSEcCtD
Rimexolone—Scab—Capecitabine—breast cancer	0.00113	0.0201	CcSEcCtD
Rimexolone—Lacrimation—Irinotecan—breast cancer	0.000913	0.0162	CcSEcCtD
Rimexolone—Lacrimation—Fluorouracil—breast cancer	0.000875	0.0155	CcSEcCtD
Rimexolone—Herpes simplex—Goserelin—breast cancer	0.000789	0.014	CcSEcCtD
Rimexolone—Photophobia—Vinblastine—breast cancer	0.000736	0.0131	CcSEcCtD
Rimexolone—Pharyngitis—Fulvestrant—breast cancer	0.000718	0.0128	CcSEcCtD
Rimexolone—Keratitis—Paclitaxel—breast cancer	0.000675	0.012	CcSEcCtD
Rimexolone—Dry eye—Goserelin—breast cancer	0.000672	0.0119	CcSEcCtD
Rimexolone—Lacrimation—Docetaxel—breast cancer	0.000631	0.0112	CcSEcCtD
Rimexolone—Rhinitis—Exemestane—breast cancer	0.00063	0.0112	CcSEcCtD
Rimexolone—Pharyngitis—Exemestane—breast cancer	0.000624	0.0111	CcSEcCtD
Rimexolone—Vision blurred—Toremifene—breast cancer	0.000586	0.0104	CcSEcCtD
Rimexolone—Photophobia—Thiotepa—breast cancer	0.000584	0.0104	CcSEcCtD
Rimexolone—Lacrimation increased—Irinotecan—breast cancer	0.000583	0.0103	CcSEcCtD
Rimexolone—Rhinitis—Anastrozole—breast cancer	0.00056	0.00995	CcSEcCtD
Rimexolone—Lacrimation increased—Fluorouracil—breast cancer	0.000558	0.00991	CcSEcCtD
Rimexolone—Herpes simplex—Fluorouracil—breast cancer	0.000558	0.00991	CcSEcCtD
Rimexolone—Pharyngitis—Anastrozole—breast cancer	0.000554	0.00985	CcSEcCtD
Rimexolone—Keratitis—Capecitabine—breast cancer	0.000554	0.00984	CcSEcCtD
Rimexolone—SERPINA6—pituitary gland—breast cancer	0.000545	0.0919	CbGeAlD
Rimexolone—Rhinitis—Raloxifene—breast cancer	0.000532	0.00944	CcSEcCtD
Rimexolone—Pharyngitis—Raloxifene—breast cancer	0.000526	0.00934	CcSEcCtD
Rimexolone—Oedema—Toremifene—breast cancer	0.000508	0.00901	CcSEcCtD
Rimexolone—SERPINA6—female reproductive system—breast cancer	0.000499	0.0841	CbGeAlD
Rimexolone—Headache—Fluoxymesterone—breast cancer	0.000493	0.00876	CcSEcCtD
Rimexolone—SERPINA6—adrenal gland—breast cancer	0.000487	0.0821	CbGeAlD
Rimexolone—Photophobia—Fluorouracil—breast cancer	0.000483	0.00858	CcSEcCtD
Rimexolone—Dysgeusia—Letrozole—breast cancer	0.000476	0.00846	CcSEcCtD
Rimexolone—Dysgeusia—Anastrozole—breast cancer	0.000476	0.00846	CcSEcCtD
Rimexolone—Lacrimation increased—Paclitaxel—breast cancer	0.000475	0.00844	CcSEcCtD
Rimexolone—Herpes simplex—Paclitaxel—breast cancer	0.000475	0.00844	CcSEcCtD
Rimexolone—SERPINA6—bone marrow—breast cancer	0.000471	0.0794	CbGeAlD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—AFP—breast cancer	0.00047	0.0101	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—RXRB—breast cancer	0.000462	0.00993	CbGpPWpGaD
Rimexolone—Vision blurred—Letrozole—breast cancer	0.000458	0.00814	CcSEcCtD
Rimexolone—Oedema—Exemestane—breast cancer	0.000447	0.00793	CcSEcCtD
Rimexolone—NR3C1—nipple—breast cancer	0.000437	0.0737	CbGeAlD
Rimexolone—NR3C1—Nuclear Receptors—RARB—breast cancer	0.000436	0.00937	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—KRT5—breast cancer	0.00043	0.00924	CbGpPWpGaD
Rimexolone—Lacrimation—Epirubicin—breast cancer	0.000426	0.00756	CcSEcCtD
Rimexolone—SERPINA6—endocrine gland—breast cancer	0.000422	0.0712	CbGeAlD
Rimexolone—Oedema—Ixabepilone—breast cancer	0.000421	0.00748	CcSEcCtD
Rimexolone—Discomfort—Letrozole—breast cancer	0.000409	0.00726	CcSEcCtD
Rimexolone—Discomfort—Anastrozole—breast cancer	0.000409	0.00726	CcSEcCtD
Rimexolone—Dry eye—Paclitaxel—breast cancer	0.000405	0.00718	CcSEcCtD
Rimexolone—Lacrimation increased—Docetaxel—breast cancer	0.000403	0.00715	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—KRT14—breast cancer	0.0004	0.00859	CbGpPWpGaD
Rimexolone—Oedema—Letrozole—breast cancer	0.000397	0.00705	CcSEcCtD
Rimexolone—Oedema—Anastrozole—breast cancer	0.000397	0.00705	CcSEcCtD
Rimexolone—Pruritus—Lapatinib—breast cancer	0.000396	0.00703	CcSEcCtD
Rimexolone—Lacrimation—Doxorubicin—breast cancer	0.000394	0.007	CcSEcCtD
Rimexolone—Hypotension—Ixabepilone—breast cancer	0.000394	0.00699	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—NR2F1—breast cancer	0.000392	0.00843	CbGpPWpGaD
Rimexolone—Pharyngitis—Vinblastine—breast cancer	0.000391	0.00694	CcSEcCtD
Rimexolone—Herpes simplex—Capecitabine—breast cancer	0.00039	0.00693	CcSEcCtD
Rimexolone—Lacrimation increased—Capecitabine—breast cancer	0.00039	0.00693	CcSEcCtD
Rimexolone—Keratitis—Epirubicin—breast cancer	0.000386	0.00686	CcSEcCtD
Rimexolone—Fluocinolone Acetonide—PLA2G4A—breast cancer	0.00038	0.0966	CrCbGaD
Rimexolone—Pharyngitis—Tamoxifen—breast cancer	0.000379	0.00674	CcSEcCtD
Rimexolone—Rhinitis—Goserelin—breast cancer	0.000366	0.0065	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—EBF1—breast cancer	0.000365	0.00784	CbGpPWpGaD
Rimexolone—Pruritus—Fulvestrant—breast cancer	0.000364	0.00646	CcSEcCtD
Rimexolone—Pharyngitis—Goserelin—breast cancer	0.000362	0.00644	CcSEcCtD
Rimexolone—NR3C1—embryo—breast cancer	0.00036	0.0608	CbGeAlD
Rimexolone—Pruritus—Toremifene—breast cancer	0.000359	0.00638	CcSEcCtD
Rimexolone—Keratitis—Doxorubicin—breast cancer	0.000357	0.00634	CcSEcCtD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—breast cancer	0.000353	0.00758	CbGpPWpGaD
Rimexolone—Eye pain—Paclitaxel—breast cancer	0.000352	0.00625	CcSEcCtD
Rimexolone—Headache—Lapatinib—breast cancer	0.00035	0.00622	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptors—PGR—breast cancer	0.000346	0.00744	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—CPT1A—breast cancer	0.000345	0.00743	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—RARB—breast cancer	0.000344	0.0074	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA2—breast cancer	0.00034	0.00732	CbGpPWpGaD
Rimexolone—Dry eye—Capecitabine—breast cancer	0.000332	0.0059	CcSEcCtD
Rimexolone—Dysgeusia—Tamoxifen—breast cancer	0.000326	0.00579	CcSEcCtD
Rimexolone—Headache—Fulvestrant—breast cancer	0.000322	0.00572	CcSEcCtD
Rimexolone—Headache—Toremifene—breast cancer	0.000318	0.00565	CcSEcCtD
Rimexolone—Pruritus—Exemestane—breast cancer	0.000316	0.00561	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—DLX2—breast cancer	0.000315	0.00678	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—breast cancer	0.000308	0.00662	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—PABPC1—breast cancer	0.000306	0.00658	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptors—ESR2—breast cancer	0.000305	0.00655	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—LEP—breast cancer	0.0003	0.00645	CbGpPWpGaD
Rimexolone—Vision blurred—Goserelin—breast cancer	0.0003	0.00532	CcSEcCtD
Rimexolone—Pruritus—Ixabepilone—breast cancer	0.000298	0.0053	CcSEcCtD
Rimexolone—NR3C1—epithelium—breast cancer	0.000294	0.0496	CbGeAlD
Rimexolone—Herpes simplex—Methotrexate—breast cancer	0.00029	0.00516	CcSEcCtD
Rimexolone—Eye pain—Capecitabine—breast cancer	0.000289	0.00513	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—CPT1A—breast cancer	0.000289	0.00621	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—HSP90AA1—breast cancer	0.000289	0.00621	CbGpPWpGaD
Rimexolone—Discomfort—Vinblastine—breast cancer	0.000288	0.00512	CcSEcCtD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOA1—breast cancer	0.000287	0.00617	CbGpPWpGaD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—breast cancer	0.000286	0.00615	CbGpPWpGaD
Rimexolone—Pruritus—Letrozole—breast cancer	0.000281	0.00499	CcSEcCtD
Rimexolone—Pruritus—Anastrozole—breast cancer	0.000281	0.00499	CcSEcCtD
Rimexolone—Discomfort—Tamoxifen—breast cancer	0.00028	0.00497	CcSEcCtD
Rimexolone—Headache—Exemestane—breast cancer	0.00028	0.00497	CcSEcCtD
Rimexolone—NR3C1—skin of body—breast cancer	0.00028	0.0472	CbGeAlD
Rimexolone—NR3C1—Adipogenesis—TWIST1—breast cancer	0.000276	0.00594	CbGpPWpGaD
Rimexolone—Testolactone—CYP19A1—breast cancer	0.000275	0.0699	CrCbGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—PGR—breast cancer	0.000274	0.00588	CbGpPWpGaD
Rimexolone—Lacrimation increased—Epirubicin—breast cancer	0.000272	0.00483	CcSEcCtD
Rimexolone—Herpes simplex—Epirubicin—breast cancer	0.000272	0.00483	CcSEcCtD
Rimexolone—Oedema—Tamoxifen—breast cancer	0.000272	0.00482	CcSEcCtD
Rimexolone—Rhinitis—Mitoxantrone—breast cancer	0.00027	0.0048	CcSEcCtD
Rimexolone—Rhinitis—Irinotecan—breast cancer	0.00027	0.0048	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptors—AR—breast cancer	0.000269	0.00579	CbGpPWpGaD
Rimexolone—Pharyngitis—Mitoxantrone—breast cancer	0.000268	0.00475	CcSEcCtD
Rimexolone—Discomfort—Goserelin—breast cancer	0.000267	0.00475	CcSEcCtD
Rimexolone—Oedema—Melphalan—breast cancer	0.000266	0.00472	CcSEcCtD
Rimexolone—Headache—Ixabepilone—breast cancer	0.000264	0.00469	CcSEcCtD
Rimexolone—NR3C1—endometrium—breast cancer	0.000264	0.0445	CbGeAlD
Rimexolone—Rhinitis—Gemcitabine—breast cancer	0.000263	0.00468	CcSEcCtD
Rimexolone—Pharyngitis—Gemcitabine—breast cancer	0.000261	0.00463	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—DKK1—breast cancer	0.00026	0.00559	CbGpPWpGaD
Rimexolone—Fluticasone Propionate—PLA2G4A—breast cancer	0.00026	0.066	CrCbGaD
Rimexolone—Oedema—Goserelin—breast cancer	0.000259	0.00461	CcSEcCtD
Rimexolone—Rhinitis—Fluorouracil—breast cancer	0.000259	0.0046	CcSEcCtD
Rimexolone—Pharyngitis—Fluorouracil—breast cancer	0.000256	0.00455	CcSEcCtD
Rimexolone—Vision blurred—Thiotepa—breast cancer	0.000256	0.00455	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—NCOA2—breast cancer	0.000255	0.00549	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—WNT10B—breast cancer	0.000253	0.00543	CbGpPWpGaD
Rimexolone—Herpes simplex—Doxorubicin—breast cancer	0.000251	0.00446	CcSEcCtD
Rimexolone—Lacrimation increased—Doxorubicin—breast cancer	0.000251	0.00446	CcSEcCtD
Rimexolone—Headache—Letrozole—breast cancer	0.000249	0.00442	CcSEcCtD
Rimexolone—Headache—Anastrozole—breast cancer	0.000249	0.00442	CcSEcCtD
Rimexolone—Hypotension—Melphalan—breast cancer	0.000248	0.00441	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—NCOA2—breast cancer	0.000248	0.00533	CbGpPWpGaD
Rimexolone—NR3C1—uterus—breast cancer	0.000243	0.041	CbGeAlD
Rimexolone—Hypotension—Goserelin—breast cancer	0.000242	0.0043	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptors—VDR—breast cancer	0.000242	0.0052	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—ESR2—breast cancer	0.000241	0.00518	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—breast cancer	0.00024	0.00517	CbGpPWpGaD
Rimexolone—Discomfort—Vinorelbine—breast cancer	0.000239	0.00425	CcSEcCtD
Rimexolone—NR3C1—pituitary gland—breast cancer	0.000239	0.0403	CbGeAlD
Rimexolone—NR3C1—adipose tissue—breast cancer	0.000238	0.0401	CbGeAlD
Rimexolone—Headache—Idarubicin—breast cancer	0.000236	0.00419	CcSEcCtD
Rimexolone—Headache—Raloxifene—breast cancer	0.000236	0.00419	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—NRIP1—breast cancer	0.000235	0.00505	CbGpPWpGaD
Rimexolone—Dry eye—Epirubicin—breast cancer	0.000231	0.00411	CcSEcCtD
Rimexolone—Dysgeusia—Mitoxantrone—breast cancer	0.00023	0.00408	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—PTHLH—breast cancer	0.000227	0.00487	CbGpPWpGaD
Rimexolone—Vision blurred—Mitoxantrone—breast cancer	0.000221	0.00393	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—HSP90AA1—breast cancer	0.000221	0.00476	CbGpPWpGaD
Rimexolone—Rhinitis—Paclitaxel—breast cancer	0.000221	0.00392	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—EGR1—breast cancer	0.000218	0.0047	CbGpPWpGaD
Rimexolone—NR3C1—female reproductive system—breast cancer	0.000218	0.0369	CbGeAlD
Rimexolone—Pharyngitis—Paclitaxel—breast cancer	0.000218	0.00388	CcSEcCtD
Rimexolone—Hypotension—Vinorelbine—breast cancer	0.000217	0.00386	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—MIF—breast cancer	0.000217	0.00466	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—PRLR—breast cancer	0.000217	0.00466	CbGpPWpGaD
Rimexolone—Pruritus—Chlorambucil—breast cancer	0.000216	0.00383	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—NCOA1—breast cancer	0.000215	0.00463	CbGpPWpGaD
Rimexolone—Dry eye—Doxorubicin—breast cancer	0.000214	0.0038	CcSEcCtD
Rimexolone—NR3C1—adrenal gland—breast cancer	0.000213	0.036	CbGeAlD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—YBX1—breast cancer	0.000213	0.00458	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HADHB—breast cancer	0.000213	0.00458	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—AR—breast cancer	0.000213	0.00457	CbGpPWpGaD
Rimexolone—Vision blurred—Fluorouracil—breast cancer	0.000212	0.00376	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—NCOA1—breast cancer	0.000209	0.00449	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—ZNF432—breast cancer	0.000207	0.00444	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—EZH2—breast cancer	0.000206	0.00444	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—AR—breast cancer	0.000206	0.00444	CbGpPWpGaD
Rimexolone—NR3C1—bone marrow—breast cancer	0.000206	0.0348	CbGeAlD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—breast cancer	0.000206	0.00443	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—THRB—breast cancer	0.000203	0.00437	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—DDIT3—breast cancer	0.000203	0.00436	CbGpPWpGaD
Rimexolone—Eye pain—Epirubicin—breast cancer	0.000201	0.00358	CcSEcCtD
Rimexolone—NR3C1—female gonad—breast cancer	0.000199	0.0335	CbGeAlD
Rimexolone—Discomfort—Irinotecan—breast cancer	0.000197	0.00351	CcSEcCtD
Rimexolone—Discomfort—Mitoxantrone—breast cancer	0.000197	0.00351	CcSEcCtD
Rimexolone—Discomfort—Gemcitabine—breast cancer	0.000192	0.00342	CcSEcCtD
Rimexolone—Pruritus—Tamoxifen—breast cancer	0.000192	0.00341	CcSEcCtD
Rimexolone—Oedema—Irinotecan—breast cancer	0.000192	0.0034	CcSEcCtD
Rimexolone—Oedema—Mitoxantrone—breast cancer	0.000192	0.0034	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—VDR—breast cancer	0.000191	0.00411	CbGpPWpGaD
Rimexolone—Discomfort—Fluorouracil—breast cancer	0.000189	0.00336	CcSEcCtD
Rimexolone—Pruritus—Melphalan—breast cancer	0.000188	0.00334	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—SIRT1—breast cancer	0.000188	0.00404	CbGpPWpGaD
Rimexolone—Dysgeusia—Paclitaxel—breast cancer	0.000188	0.00333	CcSEcCtD
Rimexolone—Rhinitis—Docetaxel—breast cancer	0.000187	0.00332	CcSEcCtD
Rimexolone—Oedema—Gemcitabine—breast cancer	0.000187	0.00331	CcSEcCtD
Rimexolone—Eye pain—Doxorubicin—breast cancer	0.000186	0.00331	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—GATA3—breast cancer	0.000185	0.00398	CbGpPWpGaD
Rimexolone—Pharyngitis—Docetaxel—breast cancer	0.000185	0.00329	CcSEcCtD
Rimexolone—NR3C1—Nuclear Receptors—ESR1—breast cancer	0.000185	0.00397	CbGpPWpGaD
Rimexolone—NR3C1—Signaling events mediated by HDAC Class II—ESR1—breast cancer	0.000185	0.00397	CbGpPWpGaD
Rimexolone—NR3C1—endocrine gland—breast cancer	0.000185	0.0312	CbGeAlD
Rimexolone—NR3C1—AP-1 transcription factor network—TCF7L2—breast cancer	0.000184	0.00395	CbGpPWpGaD
Rimexolone—Pruritus—Goserelin—breast cancer	0.000184	0.00326	CcSEcCtD
Rimexolone—Oedema—Fluorouracil—breast cancer	0.000184	0.00326	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—GATA3—breast cancer	0.000183	0.00394	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA2—breast cancer	0.000182	0.00391	CbGpPWpGaD
Rimexolone—Rhinitis—Capecitabine—breast cancer	0.000181	0.00321	CcSEcCtD
Rimexolone—Vision blurred—Paclitaxel—breast cancer	0.00018	0.0032	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—NCOA2—breast cancer	0.00018	0.00387	CbGpPWpGaD
Rimexolone—Pharyngitis—Capecitabine—breast cancer	0.000179	0.00318	CcSEcCtD
Rimexolone—Hypotension—Mitoxantrone—breast cancer	0.000179	0.00318	CcSEcCtD
Rimexolone—Hypotension—Irinotecan—breast cancer	0.000179	0.00318	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—PPARGC1B—breast cancer	0.000175	0.00377	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—breast cancer	0.000175	0.00377	CbGpPWpGaD
Rimexolone—Headache—Vinblastine—breast cancer	0.000175	0.00311	CcSEcCtD
Rimexolone—NR3C1—Circadian Clock—NCOR1—breast cancer	0.000175	0.00376	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—EGR1—breast cancer	0.000175	0.00376	CbGpPWpGaD
Rimexolone—Hypotension—Gemcitabine—breast cancer	0.000174	0.0031	CcSEcCtD
Rimexolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—breast cancer	0.000172	0.0037	CbGpPWpGaD
Rimexolone—Fluticasone Propionate—PGR—breast cancer	0.000172	0.0436	CrCbGaD
Rimexolone—Hypotension—Fluorouracil—breast cancer	0.000171	0.00305	CcSEcCtD
Rimexolone—Headache—Tamoxifen—breast cancer	0.00017	0.00302	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—breast cancer	0.000166	0.00358	CbGpPWpGaD
Rimexolone—Pruritus—Vinorelbine—breast cancer	0.000164	0.00292	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—AHR—breast cancer	0.000163	0.0035	CbGpPWpGaD
Rimexolone—Headache—Goserelin—breast cancer	0.000163	0.00289	CcSEcCtD
Rimexolone—Discomfort—Paclitaxel—breast cancer	0.000161	0.00286	CcSEcCtD
Rimexolone—Dysgeusia—Docetaxel—breast cancer	0.000159	0.00282	CcSEcCtD
Rimexolone—Betamethasone—PGR—breast cancer	0.000157	0.04	CrCbGaD
Rimexolone—Pruritus—Thiotepa—breast cancer	0.000157	0.00279	CcSEcCtD
Rimexolone—Oedema—Paclitaxel—breast cancer	0.000156	0.00278	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—HSP90AA1—breast cancer	0.000156	0.00335	CbGpPWpGaD
Rimexolone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—breast cancer	0.000155	0.00334	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—EGR1—breast cancer	0.000154	0.00331	CbGpPWpGaD
Rimexolone—Dysgeusia—Capecitabine—breast cancer	0.000154	0.00273	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOA1—breast cancer	0.000153	0.0033	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—SMAD4—breast cancer	0.000152	0.00327	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—PRL—breast cancer	0.000152	0.00326	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—NCOA1—breast cancer	0.000152	0.00326	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—WNT1—breast cancer	0.000149	0.00321	CbGpPWpGaD
Rimexolone—Vision blurred—Capecitabine—breast cancer	0.000148	0.00263	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—FOXM1—breast cancer	0.000148	0.00317	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—HIF1A—breast cancer	0.000148	0.00317	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AR—breast cancer	0.000147	0.00316	CbGpPWpGaD
Rimexolone—NR3C1—Nuclear Receptor transcription pathway—ESR1—breast cancer	0.000146	0.00314	CbGpPWpGaD
Rimexolone—Hypotension—Paclitaxel—breast cancer	0.000146	0.00259	CcSEcCtD
Rimexolone—Headache—Vinorelbine—breast cancer	0.000146	0.00258	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—BMP4—breast cancer	0.000145	0.00312	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NR2F1—breast cancer	0.000143	0.00308	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CSF2—breast cancer	0.000143	0.00307	CbGpPWpGaD
Rimexolone—Headache—Thiotepa—breast cancer	0.000139	0.00247	CcSEcCtD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—breast cancer	0.000139	0.00298	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—STAT5A—breast cancer	0.000135	0.00291	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—BMP2—breast cancer	0.000135	0.0029	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—breast cancer	0.000135	0.0029	CbGpPWpGaD
Rimexolone—Pharyngitis—Methotrexate—breast cancer	0.000133	0.00237	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—NR2F6—breast cancer	0.000133	0.00286	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—HNF4G—breast cancer	0.000133	0.00286	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—ALDOA—breast cancer	0.000133	0.00286	CbGpPWpGaD
Rimexolone—Oedema—Docetaxel—breast cancer	0.000132	0.00235	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—breast cancer	0.000132	0.00284	CbGpPWpGaD
Rimexolone—Discomfort—Capecitabine—breast cancer	0.000132	0.00235	CcSEcCtD
Rimexolone—Pruritus—Gemcitabine—breast cancer	0.000132	0.00235	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—breast cancer	0.000132	0.00284	CbGpPWpGaD
Rimexolone—Triamcinolone—BCHE—breast cancer	0.000131	0.0334	CrCbGaD
Rimexolone—Pruritus—Fluorouracil—breast cancer	0.00013	0.00231	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—breast cancer	0.000128	0.00276	CbGpPWpGaD
Rimexolone—Oedema—Capecitabine—breast cancer	0.000128	0.00228	CcSEcCtD
Rimexolone—NR3C1—lymph node—breast cancer	0.000128	0.0216	CbGeAlD
Rimexolone—NR3C1—Adipogenesis—GATA3—breast cancer	0.000127	0.00273	CbGpPWpGaD
Rimexolone—Rhinitis—Epirubicin—breast cancer	0.000126	0.00224	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CSF2—breast cancer	0.000126	0.0027	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CPT1A—breast cancer	0.000125	0.0027	CbGpPWpGaD
Rimexolone—Pharyngitis—Epirubicin—breast cancer	0.000125	0.00222	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—NCOA2—breast cancer	0.000125	0.00268	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—BAX—breast cancer	0.000124	0.00266	CbGpPWpGaD
Rimexolone—Hypotension—Docetaxel—breast cancer	0.000124	0.0022	CcSEcCtD
Rimexolone—Dexamethasone—CYP17A1—breast cancer	0.000123	0.0314	CrCbGaD
Rimexolone—Clobetasol propionate—CYP1A1—breast cancer	0.000123	0.0314	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MMP1—breast cancer	0.000123	0.00264	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—HIF1A—breast cancer	0.000122	0.00262	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—PLAU—breast cancer	0.00012	0.00259	CbGpPWpGaD
Rimexolone—Headache—Mitoxantrone—breast cancer	0.00012	0.00213	CcSEcCtD
Rimexolone—Headache—Irinotecan—breast cancer	0.00012	0.00213	CcSEcCtD
Rimexolone—Hypotension—Capecitabine—breast cancer	0.00012	0.00213	CcSEcCtD
Rimexolone—Headache—Gemcitabine—breast cancer	0.000117	0.00208	CcSEcCtD
Rimexolone—Rhinitis—Doxorubicin—breast cancer	0.000117	0.00207	CcSEcCtD
Rimexolone—Pharyngitis—Doxorubicin—breast cancer	0.000115	0.00205	CcSEcCtD
Rimexolone—Headache—Fluorouracil—breast cancer	0.000115	0.00204	CcSEcCtD
Rimexolone—Hydrocortisone—SHBG—breast cancer	0.000115	0.0292	CrCbGaD
Rimexolone—Dysgeusia—Methotrexate—breast cancer	0.000115	0.00203	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—ESR1—breast cancer	0.000113	0.00244	CbGpPWpGaD
Rimexolone—NR3C1—Circadian Clock—SERPINE1—breast cancer	0.000113	0.00243	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—NOTCH1—breast cancer	0.000112	0.00241	CbGpPWpGaD
Rimexolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—breast cancer	0.000112	0.00241	CbGpPWpGaD
Rimexolone—Pruritus—Paclitaxel—breast cancer	0.000111	0.00196	CcSEcCtD
Rimexolone—Vision blurred—Methotrexate—breast cancer	0.00011	0.00196	CcSEcCtD
Rimexolone—NR3C1—Endoderm Differentiation—APC—breast cancer	0.00011	0.00236	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—GATA3—breast cancer	0.00011	0.00236	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—breast cancer	0.000108	0.00232	CbGpPWpGaD
Rimexolone—Betamethasone—CYP19A1—breast cancer	0.000108	0.0274	CrCbGaD
Rimexolone—Dysgeusia—Epirubicin—breast cancer	0.000107	0.0019	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK2—breast cancer	0.000107	0.0023	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—MDM2—breast cancer	0.000105	0.00227	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—NCOA1—breast cancer	0.000105	0.00226	CbGpPWpGaD
Rimexolone—Vision blurred—Epirubicin—breast cancer	0.000103	0.00183	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—FOS—breast cancer	0.000102	0.0022	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—breast cancer	0.000101	0.00218	CbGpPWpGaD
Rimexolone—Hydrocortamate—CYP3A4—breast cancer	0.000101	0.0257	CrCbGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—breast cancer	0.000101	0.00217	CbGpPWpGaD
Rimexolone—Dexamethasone—NOS2—breast cancer	0.000101	0.0256	CrCbGaD
Rimexolone—NR3C1—Gene Expression—ZNF432—breast cancer	9.95e-05	0.00214	CbGpPWpGaD
Rimexolone—Dysgeusia—Doxorubicin—breast cancer	9.92e-05	0.00176	CcSEcCtD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—ESR2—breast cancer	9.85e-05	0.00212	CbGpPWpGaD
Rimexolone—Discomfort—Methotrexate—breast cancer	9.84e-05	0.00175	CcSEcCtD
Rimexolone—Headache—Paclitaxel—breast cancer	9.79e-05	0.00174	CcSEcCtD
Rimexolone—Vision blurred—Doxorubicin—breast cancer	9.55e-05	0.0017	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—ESRRA—breast cancer	9.49e-05	0.00204	CbGpPWpGaD
Rimexolone—Budesonide—CYP3A4—breast cancer	9.38e-05	0.0239	CrCbGaD
Rimexolone—Pruritus—Docetaxel—breast cancer	9.37e-05	0.00166	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—STAT5A—breast cancer	9.36e-05	0.00201	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—EGR1—breast cancer	9.21e-05	0.00198	CbGpPWpGaD
Rimexolone—Discomfort—Epirubicin—breast cancer	9.21e-05	0.00164	CcSEcCtD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—JUN—breast cancer	9.17e-05	0.00197	CbGpPWpGaD
Rimexolone—Dexamethasone—PGR—breast cancer	9.14e-05	0.0233	CrCbGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—breast cancer	9.09e-05	0.00195	CbGpPWpGaD
Rimexolone—Pruritus—Capecitabine—breast cancer	9.07e-05	0.00161	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—FOS—breast cancer	9e-05	0.00194	CbGpPWpGaD
Rimexolone—Oedema—Epirubicin—breast cancer	8.93e-05	0.00159	CcSEcCtD
Rimexolone—Hypotension—Methotrexate—breast cancer	8.92e-05	0.00158	CcSEcCtD
Rimexolone—Ciclesonide—CYP2D6—breast cancer	8.91e-05	0.0227	CrCbGaD
Rimexolone—NR3C1—Adipogenesis—NCOR1—breast cancer	8.8e-05	0.00189	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—AR—breast cancer	8.7e-05	0.00187	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—MAPK8—breast cancer	8.67e-05	0.00186	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—THRB—breast cancer	8.58e-05	0.00184	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP1B1—breast cancer	8.55e-05	0.0217	CrCbGaD
Rimexolone—Discomfort—Doxorubicin—breast cancer	8.52e-05	0.00151	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—E2F1—breast cancer	8.51e-05	0.00183	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IFNG—breast cancer	8.49e-05	0.00182	CbGpPWpGaD
Rimexolone—Hypotension—Epirubicin—breast cancer	8.35e-05	0.00148	CcSEcCtD
Rimexolone—Headache—Docetaxel—breast cancer	8.3e-05	0.00147	CcSEcCtD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—breast cancer	8.29e-05	0.00178	CbGpPWpGaD
Rimexolone—Oedema—Doxorubicin—breast cancer	8.27e-05	0.00147	CcSEcCtD
Rimexolone—NR3C1—Generic Transcription Pathway—RXRB—breast cancer	8.23e-05	0.00177	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of Androgen receptor activity—SRC—breast cancer	8.22e-05	0.00177	CbGpPWpGaD
Rimexolone—Alclometasone—CYP3A4—breast cancer	8.08e-05	0.0206	CrCbGaD
Rimexolone—Headache—Capecitabine—breast cancer	8.03e-05	0.00143	CcSEcCtD
Rimexolone—Hydrocortisone—ABCG2—breast cancer	7.91e-05	0.0201	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CXCL8—breast cancer	7.89e-05	0.0017	CbGpPWpGaD
Rimexolone—Flunisolide—CYP3A4—breast cancer	7.87e-05	0.02	CrCbGaD
Rimexolone—Paramethasone—CYP3A4—breast cancer	7.77e-05	0.0198	CrCbGaD
Rimexolone—Hypotension—Doxorubicin—breast cancer	7.72e-05	0.00137	CcSEcCtD
Rimexolone—NR3C1—AP-1 transcription factor network—CDKN1B—breast cancer	7.71e-05	0.00166	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HES1—breast cancer	7.65e-05	0.00164	CbGpPWpGaD
Rimexolone—Ciclesonide—CYP3A4—breast cancer	7.65e-05	0.0194	CrCbGaD
Rimexolone—Fluorometholone—CYP3A4—breast cancer	7.58e-05	0.0193	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IL2—breast cancer	7.54e-05	0.00162	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HNRNPK—breast cancer	7.54e-05	0.00162	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HNRNPR—breast cancer	7.54e-05	0.00162	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—breast cancer	7.48e-05	0.00161	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—CTNNB1—breast cancer	7.45e-05	0.0016	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MDM2—breast cancer	7.44e-05	0.0016	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—HIF1A—breast cancer	7.41e-05	0.00159	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—RELA—breast cancer	7.38e-05	0.00159	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CCND1—breast cancer	7.35e-05	0.00158	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—JUN—breast cancer	7.34e-05	0.00158	CbGpPWpGaD
Rimexolone—Methylprednisolone—CYP3A4—breast cancer	7.33e-05	0.0187	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—CTNNB1—breast cancer	7.28e-05	0.00157	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—LEP—breast cancer	7.24e-05	0.00156	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MMP9—breast cancer	7.14e-05	0.00153	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—PTEN—breast cancer	7.1e-05	0.00153	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—breast cancer	6.95e-05	0.0015	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EEF1B2—breast cancer	6.9e-05	0.00148	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NR2F1—breast cancer	6.9e-05	0.00148	CbGpPWpGaD
Rimexolone—Pruritus—Methotrexate—breast cancer	6.75e-05	0.0012	CcSEcCtD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—breast cancer	6.64e-05	0.00143	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—breast cancer	6.53e-05	0.0014	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—breast cancer	6.46e-05	0.00139	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HNF4G—breast cancer	6.41e-05	0.00138	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NR2F6—breast cancer	6.41e-05	0.00138	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—breast cancer	6.41e-05	0.00138	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—breast cancer	6.33e-05	0.00136	CbGpPWpGaD
Rimexolone—Pruritus—Epirubicin—breast cancer	6.32e-05	0.00112	CcSEcCtD
Rimexolone—Dexamethasone—CYP19A1—breast cancer	6.27e-05	0.016	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—breast cancer	6.27e-05	0.00135	CbGpPWpGaD
Rimexolone—Triamcinolone—CYP3A4—breast cancer	6.18e-05	0.0157	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—breast cancer	6.12e-05	0.00132	CbGpPWpGaD
Rimexolone—Methylprednisolone—ABCB1—breast cancer	6.1e-05	0.0155	CrCbGaD
Rimexolone—Triamcinolone—PTGS2—breast cancer	6.05e-05	0.0154	CrCbGaD
Rimexolone—NR3C1—Adipogenesis—RB1—breast cancer	6.03e-05	0.0013	CbGpPWpGaD
Rimexolone—NR3C1—Endoderm Differentiation—TGFB1—breast cancer	6.02e-05	0.00129	CbGpPWpGaD
Rimexolone—Headache—Methotrexate—breast cancer	5.98e-05	0.00106	CcSEcCtD
Rimexolone—NR3C1—Adipogenesis—IGF1—breast cancer	5.98e-05	0.00129	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—RARB—breast cancer	5.95e-05	0.00128	CbGpPWpGaD
Rimexolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—breast cancer	5.93e-05	0.00127	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—MYC—breast cancer	5.9e-05	0.00127	CbGpPWpGaD
Rimexolone—Dexamethasone—ABCG2—breast cancer	5.89e-05	0.015	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—TGFB1—breast cancer	5.88e-05	0.00126	CbGpPWpGaD
Rimexolone—Pruritus—Doxorubicin—breast cancer	5.85e-05	0.00104	CcSEcCtD
Rimexolone—NR3C1—Gene Expression—HNRNPL—breast cancer	5.71e-05	0.00123	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—MED12—breast cancer	5.7e-05	0.00123	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—SERPINE1—breast cancer	5.68e-05	0.00122	CbGpPWpGaD
Rimexolone—Prednisone—CYP3A4—breast cancer	5.61e-05	0.0143	CrCbGaD
Rimexolone—Headache—Epirubicin—breast cancer	5.6e-05	0.000994	CcSEcCtD
Rimexolone—Fluticasone Propionate—CYP3A4—breast cancer	5.53e-05	0.0141	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—breast cancer	5.34e-05	0.00115	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—breast cancer	5.25e-05	0.00113	CbGpPWpGaD
Rimexolone—Headache—Doxorubicin—breast cancer	5.18e-05	0.00092	CcSEcCtD
Rimexolone—Prednisolone—CYP3A4—breast cancer	5.17e-05	0.0132	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NOTCH4—breast cancer	5.17e-05	0.00111	CbGpPWpGaD
Rimexolone—Betamethasone—CYP3A4—breast cancer	5.06e-05	0.0129	CrCbGaD
Rimexolone—Betamethasone—PTGS2—breast cancer	4.96e-05	0.0126	CrCbGaD
Rimexolone—Prednisone—ALB—breast cancer	4.89e-05	0.0124	CrCbGaD
Rimexolone—NR3C1—AP-1 transcription factor network—TP53—breast cancer	4.84e-05	0.00104	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—PGR—breast cancer	4.72e-05	0.00102	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EIF2S2—breast cancer	4.71e-05	0.00101	CbGpPWpGaD
Rimexolone—Prednisone—ABCB1—breast cancer	4.67e-05	0.0119	CrCbGaD
Rimexolone—Dexamethasone—CYP1A1—breast cancer	4.61e-05	0.0117	CrCbGaD
Rimexolone—NR3C1—Gene Expression—ESRRA—breast cancer	4.57e-05	0.000982	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOA2—breast cancer	4.55e-05	0.000978	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—CTNNB1—breast cancer	4.44e-05	0.000954	CbGpPWpGaD
Rimexolone—NR3C1—AP-1 transcription factor network—IL6—breast cancer	4.43e-05	0.000953	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—PARP1—breast cancer	4.39e-05	0.000944	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NOTCH3—breast cancer	4.39e-05	0.000944	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—CDKN1A—breast cancer	4.33e-05	0.000932	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—YBX1—breast cancer	4.33e-05	0.000931	CbGpPWpGaD
Rimexolone—Prednisolone—ABCB1—breast cancer	4.3e-05	0.0109	CrCbGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—breast cancer	4.27e-05	0.000917	CbGpPWpGaD
Rimexolone—Betamethasone—ABCB1—breast cancer	4.22e-05	0.0107	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—ESR2—breast cancer	4.16e-05	0.000894	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—breast cancer	4.16e-05	0.000894	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EEF2—breast cancer	4.13e-05	0.000888	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—THRB—breast cancer	4.13e-05	0.000888	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL1B—breast cancer	3.99e-05	0.000857	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CASP3—breast cancer	3.98e-05	0.000855	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—TET2—breast cancer	3.96e-05	0.000852	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RXRB—breast cancer	3.96e-05	0.000852	CbGpPWpGaD
Rimexolone—Hydrocortisone—CYP3A4—breast cancer	3.95e-05	0.0101	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NOTCH2—breast cancer	3.94e-05	0.000847	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—breast cancer	3.91e-05	0.00084	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPL31—breast cancer	3.88e-05	0.000835	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—STAT3—breast cancer	3.87e-05	0.000832	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—JUN—breast cancer	3.86e-05	0.000831	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—breast cancer	3.83e-05	0.000825	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOA1—breast cancer	3.83e-05	0.000824	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—AR—breast cancer	3.67e-05	0.00079	CbGpPWpGaD
Rimexolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—breast cancer	3.64e-05	0.000782	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPS4X—breast cancer	3.62e-05	0.000779	CbGpPWpGaD
Rimexolone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—breast cancer	3.6e-05	0.000775	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—TGFB1—breast cancer	3.59e-05	0.000771	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EIF3A—breast cancer	3.57e-05	0.000767	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT3A—breast cancer	3.51e-05	0.000755	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ELL—breast cancer	3.46e-05	0.000744	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP2D6—breast cancer	3.43e-05	0.00874	CrCbGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—breast cancer	3.38e-05	0.000726	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—TNF—breast cancer	3.35e-05	0.00072	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—SMAD4—breast cancer	3.31e-05	0.000711	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—VDR—breast cancer	3.3e-05	0.00071	CbGpPWpGaD
Rimexolone—Hydrocortisone—ABCB1—breast cancer	3.29e-05	0.00837	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NCOR1—breast cancer	3.21e-05	0.000691	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—PABPC1—breast cancer	3.2e-05	0.000689	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT3B—breast cancer	3e-05	0.000645	CbGpPWpGaD
Rimexolone—Dexamethasone—CYP3A4—breast cancer	2.95e-05	0.00749	CrCbGaD
Rimexolone—NR3C1—Gene Expression—RPL23A—breast cancer	2.94e-05	0.000633	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—TNF—breast cancer	2.89e-05	0.000622	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HIST1H2BK—breast cancer	2.89e-05	0.000621	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HIST1H2BC—breast cancer	2.89e-05	0.000621	CbGpPWpGaD
Rimexolone—Dexamethasone—PTGS2—breast cancer	2.88e-05	0.00734	CrCbGaD
Rimexolone—NR3C1—Gene Expression—RARB—breast cancer	2.86e-05	0.000616	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPS8—breast cancer	2.75e-05	0.00059	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPS7—breast cancer	2.75e-05	0.00059	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MED12—breast cancer	2.75e-05	0.00059	CbGpPWpGaD
Rimexolone—NR3C1—Adipogenesis—IL6—breast cancer	2.7e-05	0.000581	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—ESR1—breast cancer	2.52e-05	0.000542	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NOTCH4—breast cancer	2.49e-05	0.000535	CbGpPWpGaD
Rimexolone—Dexamethasone—ABCB1—breast cancer	2.45e-05	0.00624	CrCbGaD
Rimexolone—NR3C1—Generic Transcription Pathway—NOTCH1—breast cancer	2.44e-05	0.000524	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—HSPA1B—breast cancer	2.37e-05	0.00051	CbGpPWpGaD
Rimexolone—NR3C1—SIDS Susceptibility Pathways—IL6—breast cancer	2.33e-05	0.000502	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—PGR—breast cancer	2.27e-05	0.000489	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—DNMT1—breast cancer	2.23e-05	0.00048	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOA2—breast cancer	2.19e-05	0.000471	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—EZH2—breast cancer	2.16e-05	0.000465	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—PARP1—breast cancer	2.11e-05	0.000455	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NOTCH3—breast cancer	2.11e-05	0.000455	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—SERPINE1—breast cancer	2.07e-05	0.000446	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—RPS6—breast cancer	2.06e-05	0.000444	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ESR2—breast cancer	2e-05	0.000431	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NOTCH2—breast cancer	1.9e-05	0.000408	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOA1—breast cancer	1.85e-05	0.000397	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AR—breast cancer	1.77e-05	0.00038	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SIRT1—breast cancer	1.61e-05	0.000347	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SMAD4—breast cancer	1.59e-05	0.000342	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—VDR—breast cancer	1.59e-05	0.000342	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NCOR1—breast cancer	1.55e-05	0.000332	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—H2AFX—breast cancer	1.51e-05	0.000324	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ERCC2—breast cancer	1.45e-05	0.000313	CbGpPWpGaD
Rimexolone—NR3C1—Generic Transcription Pathway—MYC—breast cancer	1.31e-05	0.000282	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—ESR1—breast cancer	1.21e-05	0.000261	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—NOTCH1—breast cancer	1.17e-05	0.000252	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—SERPINE1—breast cancer	9.98e-06	0.000215	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MAPK3—breast cancer	6.5e-06	0.00014	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—MYC—breast cancer	6.32e-06	0.000136	CbGpPWpGaD
Rimexolone—NR3C1—Gene Expression—AKT1—breast cancer	4.38e-06	9.42e-05	CbGpPWpGaD
